Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 广州白云山医药集团股份有限公司主要是以医药制造为主，产品主要包括：中成药、中药饮片、化学制剂、化学原料药等。公司拥有中国驰名商标4项、广东省著名商标20项、广州市著名商标27项。在药物剂型方面，拥有化学药剂型21种、中成药剂型16种等近2,000个品种规格，包括国家一类新药3个，二类新药9个，中药保护品种71个，独家生产品种31个。
Main Business 中西成药、化学原料药、天然药物、生物医药、化学原料药中间体的研究开发、制造与销售;西药、中药和医疗器械的批发、零售和进出口业务;大健康产品的研发、生产与销售;医疗服务、健康管理、养生养老等健康产业投资
Legal Representative 李楚源
Top Executives
董事长(代)：杨军
副董事长：杨军,程宁
执行董事：黎洪,刘菊妍,吴长海,程宁,杨军
独立董事：孙宝清,黄龙德,陈亚进,黄民
Top 5 Shareholder
Shareholder name Nature Holding Date
广州医药集团有限公司流通A股45.04%30/09/2024
HKSCC Nominees LimitedH股13.52%30/09/2024
广州国寿城市发展产业投资企业（有限合伙）流通A股4.16%30/09/2024
中国证券金融股份有限公司流通A股2.91%30/09/2024
香港中央结算有限公司流通A股2.15%30/09/2024
Company Secretary 黄雪贞
Solicitors 国浩律师（上海）事务所
Auditors 立信会计师事务所（特殊普通合伙）
Tel No 020-66281218;020-66281216
Fax No 020-66281229
Website www.gybys.com.cn
Email sec@gybys.com.cn
Company Address
Register: 中国广东省广州市荔湾区沙面北街45号
Office: 中国广东省广州市荔湾区沙面北街45号
Listing Date 06/02/2001
Shares Capital
Shares Capital: 1,625,790,949
Total A Share: 1,405,890,949
Listed A Share: 1,405,890,949
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 219,900,000
EPS(RMB)* ¥ 2.495
DPS(RMB)* ¥ 0.749
NBV Per Share(RMB)* ¥ 21.478
Market Capitalization(RMB) 41.572B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.